Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haidebao Body Lotion (HBL) is a topical dermatological product developed for the relief of symptoms associated with atopic dermatitis, such as itching and skin inflammation. It incorporates CAPCS (cocamidopropyl cetyl dimethyl ammonium chloride), an ingredient likely used for its antimicrobial and skin barrier protective properties. HBL is the subject of ongoing clinical trials to evaluate its safety and efficacy for patients with mild atopic dermatitis[3][7]. The full mechanism of action and all ingredients have not been completely disclosed in public trial registries or publications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Haidebao Body Lotion.